Shang-Ta Wang

Title: Innovations by Shang-Ta Wang

Introduction

Shang-Ta Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the treatment and prevention of diseases associated with bone mass reduction. With a total of 2 patents, his work focuses on enhancing bone health and addressing osteoporosis.

Latest Patents

Shang-Ta Wang's latest patents include a method for the treatment or prevention of diseases associated with a decrease in bone mass. This invention involves administering a composition containing an effective amount of genistein phosphate conjugate to individuals in need. The method aims to improve bone architecture and bio-mechanical strength, effectively increasing bone mineral content and density while reducing the risk of complications in menopausal women. Another significant patent involves the biotransformation of benzopyrone compounds into phosphate-conjugated derivatives. This process utilizes an isolated polypeptide with benzopyrone phosphate synthetase activity, enhancing the hydrophilic properties of the compounds.

Career Highlights

Throughout his career, Shang-Ta Wang has worked with reputable organizations such as Hughes Biotechnology Co., Ltd and National Taiwan University. His experience in these institutions has allowed him to develop innovative solutions in the field of bone health.

Collaborations

Shang-Ta Wang has collaborated with notable colleagues, including Chen Yu Hsu and Nan-Wei Su. Their joint efforts have contributed to advancements in their respective fields.

Conclusion

Shang-Ta Wang's contributions to biomedical research and his innovative patents demonstrate his commitment to improving health outcomes related to bone mass and osteoporosis. His work continues to influence the field and offers promising solutions for those in need.